These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27302674)

  • 21. Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.
    Jitmuang A; Nation RL; Koomanachai P; Chen G; Lee HJ; Wasuwattakul S; Sritippayawan S; Li J; Thamlikitkul V; Landersdorfer CB
    J Antimicrob Chemother; 2015; 70(6):1804-11. PubMed ID: 25698772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairment.
    Leroy A; Fillastre JP; Borsa-Lebas F; Etienne I; Humbert G
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2794-8. PubMed ID: 1482147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of meropenem in patients with liver disease.
    Thyrum PT; Yeh C; Birmingham B; Lasseter K
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S184-90. PubMed ID: 9126692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of meropenem in subjects with various degrees of renal impairment.
    Christensson BA; Nilsson-Ehle I; Hutchison M; Haworth SJ; Oqvist B; Norrby SR
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1532-7. PubMed ID: 1510451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem.
    Burman LA; Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
    J Antimicrob Chemother; 1991 Feb; 27(2):219-24. PubMed ID: 2055812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains.
    Adnan S; Li JX; Wallis SC; Rudd M; Jarrett P; Paterson DL; Lipman J; Udy AA; Roberts JA
    Int J Antimicrob Agents; 2013 Jul; 42(1):90-3. PubMed ID: 23590897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease.
    Ohashi N; Uematsu T; Nagashima S; Kanamaru M; Tajima N; Togawa A; Hishida A
    J Infect Chemother; 2005 Feb; 11(1):24-31. PubMed ID: 15729484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes.
    Jones HK; Kelly HC; Hutchison M; Yates RA; Ross F; Lomax C; Freestone S; Webb D
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):193-9. PubMed ID: 9358198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meropenem removal in critically ill patients undergoing sustained low-efficiency dialysis (SLED).
    Deshpande P; Chen J; Gofran A; Murea M; Golestaneh L
    Nephrol Dial Transplant; 2010 Aug; 25(8):2632-6. PubMed ID: 20181801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
    Jamal JA; Udy AA; Lipman J; Roberts JA
    Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma pharmacokinetics and urine concentrations of meropenem in ewes.
    Abo El Sooud K
    J Vet Pharmacol Ther; 2004 Feb; 27(1):27-30. PubMed ID: 14995963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients.
    Kees MG; Minichmayr IK; Moritz S; Beck S; Wicha SG; Kees F; Kloft C; Steinke T
    J Clin Pharmacol; 2016 Mar; 56(3):307-15. PubMed ID: 26222202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children.
    Blumer JL; Reed MD; Kearns GL; Jacobs RF; Gooch WM; Yogev R; Willims K; Ewing BJ
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1721-5. PubMed ID: 7486908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of meropenem in plasma and filtrate-dialysate from patients under continuous veno-venous haemodiafiltration by SPE-LC.
    Robatel C; Buclin T; Eckert P; Schaller MD; Biollaz J; Decosterd LA
    J Pharm Biomed Anal; 2002 Jun; 29(1-2):17-33. PubMed ID: 12062661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the pharmacodynamics of meropenem in healthy volunteers following administration by intermittent infusion or bolus injection.
    Jaruratanasirikul S; Sriwiriyajan S
    J Antimicrob Chemother; 2003 Sep; 52(3):518-21. PubMed ID: 12917242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis.
    Tsaganos T; Kouki P; Digenis P; Giamarellou H; Giamarellos-Bourboulis EJ; Kanellakopoulou K
    Int J Antimicrob Agents; 2008 Jul; 32(1):46-9. PubMed ID: 18534825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosing optimization of meropenem based on a pharmacokinetic analysis in patients receiving hemodiafiltration and an in vitro model.
    Yokoyama Y; Nishino K; Matsumoto K; Inomoto Y; Matsuda K; Nakamura RN; Yasuno N; Kizu J
    J Infect Chemother; 2018 Feb; 24(2):92-98. PubMed ID: 29054458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state pharmacokinetics and pharmacodynamics of meropenem in hospitalized patients.
    Cheatham SC; Kays MB; Smith DW; Wack MF; Sowinski KM
    Pharmacotherapy; 2008 Jun; 28(6):691-8. PubMed ID: 18503396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and pharmacodynamic properties of meropenem.
    Nicolau DP
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S32-40. PubMed ID: 18713048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.